Linda T. Vahdat

机构：Dartmouth College, Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth–Hitchcock Medical Center, Cotton (United States), Dartmouth Psychiatric Research Center, Dartmouth Cancer Center · ORCID：0000-0002-3522-7382

发表论文 488 篇 · 总被引 19430 次 · h-index 67

代表论文

• SWIVEL: A randomized phase II trial of switching medications versus guideline-directed interventions for adjuvant aromatase inhibitor side effects in breast cancer patients. (2026 · Journal of Clinical Oncology · 被引 1)
• Abstract CT072: Novel targeting of the microenvironment to decrease metastatic recurrence of high-risk TNBC: A randomized phase II study of tetrathiomolybdate (TM) plus capecitabine in patients with breast cancer at high risk of recurrence (2026 · Cancer Research · 被引 1)
• Figure 2 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer (2026)
• Table S2 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer (2026)
• Figure 3 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer (2026)
• Figure S2 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer (2026)